Partner Content Partner Content Chairs from Aerie Pharmaceuticals & Santen Inc Invitation to... Ophthalmic Drugs Conference Invitation
Partner Content Partner Content Registration opens for SMi’s 4th Annual Ophthalmic Drugs Con... Registration opens for Ophthalmic Drugs Conference
Partner Content Partner Content Speaker Interview with iVeena Released for 3rd Ophthalmic Dr... Ophthalmic Drugs Conference Speaker Interview
Partner Content Partner Content Explore the future of ocular gene editing and strategic drug... Ophthalmic Drugs Conference
News MSD joins PD-1/VEGF push in cancer with LaNova deal There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy.
Sales & Marketing Sponsored Enabling site success: Key insights to reducing burden and i... Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
